Cargando…
Outcomes and Management of Sars-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation (HCT) and CAR-T Therapy
Autores principales: | Infante, Maria Stefania, DeWolf, Susan, Tamari, Roni, Dahi, Parastoo B., Lee, Yeon Joo, Politikos, Ioannis, Barker, Juliet N., Babady, N. Esther, Ramanathan, Lakshmi, Seo, Susan, Giralt, Sergio A., Kamboj, Mini, Perales, Miguel-Angel, Shah, Gunjan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665200/ http://dx.doi.org/10.1182/blood-2022-166393 |
Ejemplares similares
-
Humoral Response to COVID-19 Vaccination Given Pre-Cellular Therapy Wanes in Patients after Cellular Therapy: An Argument for Full Reimmunization
por: Shah, Gunjan L., et al.
Publicado: (2022) -
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection
por: Shah, Nishi, et al.
Publicado: (2022) -
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT
por: Shouval, Roni, et al.
Publicado: (2022) -
Timing and Immune Status after Cellular Therapies Predict Response to COVID-19 Vaccines
por: Tamari, Roni, et al.
Publicado: (2021) -
The spike gene target failure (SGTF) genomic signature is highly accurate for the identification of Alpha and Omicron SARS-CoV-2 variants
por: McMillen, Tracy, et al.
Publicado: (2022)